ArticleComputational and structural biotechnology journal2026
Adversarial Sequence Mutations in AlphaFold and ESMFold Reveal Nonphysical Structural Invariance, Confidence Failures, and Concerns for Protein Design.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RINAMI: Residue-attributed interpretable neural network for predicting absolute folding free energy by merging structure and sequence information.Protein science : a publication of the Protein Society · 2026Article
- AlphaInterp: Mechanistic Interpretability of AlphaFold 3 Reveals How Evolutionary Information Shapes Protein Structure Prediction.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
AlphaFold has transformed structural biology and spawned an ecosystem of derivative tools for protein design, binding prediction, and drug discovery. However, whether AlphaFold has learned generalizable biophysical principles as opposed to template-based pattern matching remains unclear-a distinction critical for applications beyond its training context. Here, we perform a systematic adversarial evaluation of AlphaFold 3 using point and deletion mutations across 200 proteins. Remarkably, predicted structures remain invariant to mutations of up to 40% of residues-including deliberately destabilizing substitutions-and to deletions of 10%. Notably, this invariance holds even for experimentally validated fold-switching proteins that are known to adopt alternative conformations in response to such mutations, despite the fact that these proteins are small and monomeric-precisely the category where AlphaFold is expected to perform best. Confidence metrics prove unreliable, as they select the most accurate structure at most 35% of the time and consistently correlate with the structural quality of the best available training-set template. ESMFold exhibits greater, though still imperfect, mutational sensitivity, suggesting a tighter coupling between sequence identity and predicted structure that may reflect differences in training objective rather than overall model quality. These findings indicate that AlphaFold may rely heavily on memorized templates rather than biophysical reasoning, with direct implications for mutation-effect interpretation, confidence-guided model selection, and sequence optimization workflows.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.